Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duexis for prevention of ibuprofen-associated ulcers
NCT00450216Phase 3Completed
- Sponsor
- Amgen
- Start
- Mar 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ibuprofen + famotidine in gastric ulcer, duodenal ulcer, sponsored by Amgen. Started Mar 2007; status: completed.
02
Drugs
ibuprofen + famotidine
03
Conditions
gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on NCT00450216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450216.